Salt Composition in Both
Cefpodoxime Proxetil (50mg) + Clavulanic Acid (28.5mg)

No Image Available

Teepod CV Dry Syrup

67.20

M.R.P.: ₹84.00


No related product found

Teepod CV Dry Syrup

(5 customer reviews)

67.20

M.R.P. : ₹84.00

- +
Login / Register
Views 0
Bought 0



Related Products by Salt Composition

No Image

Jaspod CV Dry Syrup

64.80

M.R.P.: ₹81.00


No Image

Vinmod-CV Dry Syrup

65.88

M.R.P.: ₹82.35


No Image

Podeck CV Dry Syrup

84.00

M.R.P.: ₹105.00


No Image

Alarpod CV Dry Syrup

84.00

M.R.P.: ₹105.00





Description

Introduction

In Treatment of Respiratory tract infection Respiratory tract infections are those infections that can affect the sinuses, throat, airways or lungs. Teepod CV Dry Syrup contains two different medicines, Cefpodoxime Proxetil and Clavulanic Acid, that work together to kill the bacteria that cause respiratory tract infections. Cefpodoxime Proxetil works by stopping the growth of bacteria. Clavulanic Acid reduces resistance and enhances the activity of Cefpodoxime Proxetil against bacteria. It usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.

Benefits

Teepod CV Dry Syrup is a combination of two medicines: Cefpodoxime Proxetil and Clavulanic Acid. Cefpodoxime Proxetil is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Clavulanic Acid is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Cefpodoxime Proxetil against bacteria.

How to use

Safety Advice

- Kidney : CAUTION - Teepod CV Dry Syrup should be used with caution in patients with severe kidney disease. Dose adjustment of Teepod CV Dry Syrup may be needed. Please consult your doctor. - Liver : CONSULT YOUR DOCTOR - There is limited information available on the use of Teepod CV Dry Syrup in patients with liver disease. Please consult your doctor.

Question & Answers